-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
ZyVersa Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
- ZyVersa Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$19.8M, a 725% decline year-over-year.
- ZyVersa Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$25.7M, a 20.5% decline year-over-year.
- ZyVersa Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$9.41M, a 90.4% increase from 2023.
- ZyVersa Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$98.3M, a 600% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)